Detalles de la búsqueda
1.
Quadriparesis and paraparesis following chimeric antigen receptor T-cell (CART) therapy in children and adolescents.
Blood;
2024 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38905637
2.
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia.
Blood Adv;
8(9): 2182-2192, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38386999
3.
Coronavirus Disease 2019 mRNA Vaccination Appears Safe in Pediatric Patients With Hypersensitivity to Polyethylene Glycolated Escherichia coli L-asparaginase.
J Pediatr Hematol Oncol;
46(2): e202-e204, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181327
4.
INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther;
30(1): 56-70, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37821078
5.
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group.
J Clin Oncol;
42(2): 218-227, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37890117
6.
Bone marrow fibrosis is associated with non-response to CD19 CAR T-cell therapy in B-acute lymphoblastic leukemia.
Am J Hematol;
98(12): 1888-1897, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37718626
7.
Co-Occurrence of Pallister-Killian Syndrome and Burkitt Lymphoma in a Patient with Near-Normal Neurocognitive Development.
Mol Syndromol;
14(4): 303-309, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589028
8.
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
Blood Adv;
7(4): 575-585, 2023 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482927
9.
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia.
Leukemia;
37(1): 53-60, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36310183
10.
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.
Blood;
141(6): 609-619, 2023 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36351239
11.
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer;
69(11): e29937, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36083863
12.
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy.
Blood Adv;
6(17): 5222-5226, 2022 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35834728
13.
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001).
Haematologica;
107(10): 2295-2303, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35112552
14.
Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies.
Blood Cancer Discov;
3(2): 103-115, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35015683
15.
Outcomes of children and young adults with T-cell acute lymphoblastic leukemia/lymphoma who present in critical status.
Pediatr Blood Cancer;
69(4): e29457, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34997812
16.
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621.
J Clin Oncol;
40(9): 956-967, 2022 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35007127
17.
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.
J Clin Oncol;
40(9): 932-944, 2022 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34767461
18.
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy.
Blood;
139(14): 2173-2185, 2022 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34871373
19.
Scalp Nodules and Facial Droop in an Infant.
Pediatrics;
148(5)2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34610947
20.
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials.
Lancet Haematol;
8(10): e711-e722, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34560014